For other, mainly antibody‐driven diseases such as AIHA and rheumatoid arthritis (RA), CP activation is key, but the role of the LP and AP in disease development and progression is often unclear.11, 20, 21. The gene discussed is CP; the disease is rheumatoid arthritis.